Medical News Today -
11 Nov 2013 12:00
The genetic make-up of a patient's tumour could be used to personalise their treatment, and help to decide whether they would benefit from receiving additional drugs as part of their radiotherapy programme, according to a recent study involving scientists from the Manchester Cancer Research Centre. Tumours with lower levels of oxygen - known as hypoxia - often respond less well to radiation therapy. There are several agents that can be given to patients before radiotherapy to reduce hypoxia, but...
Share this Article